By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Any surgical procedure carried out with the aid of robotic systems is referred to as robotic surgery or robotic surgery with assistance. In an effort to get around the drawbacks of existing minimally invasive surgical techniques and improve the skills of surgeons performing open surgery, robotic surgery was developed.
When performing dissection, hemostasis, and resection during robotically assisted minimally invasive surgery, the surgeon uses one of two methods: either a direct tele manipulator or computer control.
This is done in place of the surgeon manually moving the instruments. While tele manipulators are still an option for input in computer-controlled systems, the surgeon uses a computer system to relay control data and guide the robotic arms and their end-effectors.
The Yemen Surgical Robotics Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Oversubscribed $15 million Series A from Galen Robotics will advance the field of surgical robotics, according to the company.
The leader in digital surgery as a service, Galen Robotics, has completed the first close of a $15 million oversubscribed Series A round that included investment from Ambix Healthcare Partners of Menlo Park, California.
Galen Robotics has submitted a new collaborative soft tissue surgical robot for FDA review in an effort to fill market gaps.
Galen hopes to level the surgical playing field by eliminating the significant capital costs connected to the current generation of surgical robots.
Galen Robotics will be the first surgical robotics business to use the per-usage disposable model for its “as-a-service” launch.
The final robot prototype’s submission to the FDA was made possible thanks to the Series A. Additionally, funds will be used to build a clinical sales team, broaden engineering, increase product development, and create programmers for training surgeons.
Once approved, the Galen robot is designed to assist surgeons with very little disruption to current surgical workflows.
It is intended for minimally invasive procedures. Initial indications for Galen will concentrate on laryngological procedures.
The platform’s capabilities will be widened by upcoming clearances to include ENT, neurosurgery, spine, and cardiothoracic procedures.
We had to change our business model from hospitals paying up front for capital equipment to “as a Service” because the pandemic had a devastating impact on hospital profits due to the postponement of elective surgeries.
